YOLFTbeta
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

300357 · SHE · Healthcare / Drug Manufacturers - General

21.69CNY-0.21 (-0.96%)

Price History

Full chart

Market Stats

Previous Close21.90
Open21.91
Day Range21.59 – 22.09
52-Week Range18.65 – 35.49
Volume5.91M
Market Cap10.64B
P/E (TTM)25.41
Forward P/E0.00
EPS0.80
Dividend Yield1.23%
Beta0.37
50-Day Avg22.59
200-Day Avg25.00

About

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of diagnostic and therapeutic products for allergic diseases in China and internationally. The company offers Changdi, a skin prick test product and dust mite drops; Changhao, an Artemisia annua pollen allergen sublingual drop; and Changdian, a dust mite skin prick test diagnostic kit. It is also involved in the research and development of cells and natural medicines. The company was founded in 2002 and is headquartered in Huzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Guoqi Wang
  • Employees1.81K
  • HeadquartersNo. 636, Zhiyuan North Road, Huzhou, China, 313200, China
  • Websitehttps://www.wolwobiotech.com

Leadership

  • Mr. Guoqi WangFinancial Manager & Head of Accounting Department · b. 1974
  • Mr. Long JiDeputy Manager of the Marketing Department & Employee Representative Director · b. 1988
  • Mr. Ziqiang BiDeputy GM & Non-Independent Director · b. 1964
  • Mr. Zhenwei GuanDeputy GM & Secretary of the Board of Directors · b. 1981
  • Ms. Mushuang HuDeputy General Manager · b. 1991

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue37.41M59.33M103.18M147.52M193.61M239.51M267.11M312.09M385.58M500.74M639.35M636.21M807.69M896.02M848.19M925.39M1.06B
Growth (%)-+58.60%+73.91%+42.98%+31.25%+23.71%+11.52%+16.84%+23.55%+29.87%+27.68%-0.49%+26.95%+10.94%-5.34%+9.10%+14.81%
Cost of Revenue4.53M5.69M6.47M7.56M7.37M9.73M13.10M11.56M14.09M28.52M22.85M28.54M34.44M42.51M40.19M44.81M50.58M
Gross Profit32.88M53.64M96.70M139.96M186.24M229.78M254.00M300.53M371.49M472.23M616.50M607.67M773.25M853.50M808.00M880.58M1.01B
Gross Margin87.89%90.41%93.73%94.88%96.19%95.94%95.09%96.30%96.35%94.30%96.43%95.51%95.74%95.26%95.26%95.16%95.24%
Operating Expense23.10M35.94M55.53M79.60M104.54M117.37M119.88M149.07M155.27M200.87M273.13M286.15M380.35M457.29M463.03M511.47M597.41M
Operating Income9.78M17.70M41.17M60.36M81.69M112.41M134.12M151.46M216.22M271.36M343.37M321.52M392.91M396.21M344.97M369.11M414.41M
Operating Margin26.14%29.83%39.91%40.92%42.19%46.93%50.21%48.53%56.08%54.19%53.71%50.54%48.65%44.22%40.67%39.89%39.01%
EBITDA9.11M23.28M47.68M64.49M84.44M110.72M131.54M153.86M210.00M259.68M326.87M294.68M366.11M402.44M338.38M360.81M489.25M
EBITDA Margin24.36%39.23%46.22%43.71%43.62%46.23%49.25%49.30%54.46%51.86%51.12%46.32%45.33%44.91%39.89%38.99%46.05%
Net Income10.51M18.41M37.26M53.77M70.56M99.55M117.82M129.20M186.10M232.88M298.30M278.45M337.99M348.77M310.18M317.82M380.94M
Net Income Margin28.10%31.02%36.12%36.45%36.45%41.57%44.11%41.40%48.27%46.51%46.66%43.77%41.85%38.92%36.57%34.34%35.86%
R&D-3.92M3.82M5.77M10.09M11.00M10.30M9.24M7.70M13.48M41.17M64.87M87.93M106.02M112.20M119.88M117.10M
R&D as % of Total Revenue-6.61%3.70%3.91%5.21%4.59%3.86%2.96%2.00%2.69%6.44%10.20%10.89%11.83%13.23%12.95%11.02%
Interest Expense-16.98K540.55K320.30K68.15K92.74K95.69K0011.18M88.40K99.80K486.95K443.98K1.48M1.33M792.85K
Interest Expense % of Total Revenue-0.03%0.52%0.22%0.04%0.04%0.04%0.00%0.00%2.23%0.01%0.02%0.06%0.05%0.17%0.14%0.07%

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets121.38M110.52M147.19M191.11M263.95M531.31M611.49M696.89M848.31M1.06B1.43B1.60B1.93B2.20B2.56B2.71B2.90B
Total Liabilities9.49M20.08M19.58M9.73M12.04M17.75M28.57M41.32M47.05M62.47M76.25M76.61M135.36M170.76M258.46M250.30M185.67M
Total Equity111.86M90.42M127.58M181.36M251.91M513.55M582.91M655.58M801.26M969.52M1.27B1.46B1.74B1.98B2.19B2.35B2.62B
Cash43.49M27.43M42.00M64.06M103.34M275.47M271.81M235.47M185.81M460.04M750.77M583.68M649.99M840.69M1.17B1.12B797.22M
Total Debt-10.00M10.00M--------9.81M7.81M16.26M55.65M20.56M-
Net Debt-43.49M-17.43M-32.00M-64.06M-103.34M-275.47M-271.81M-235.47M-185.81M-460.04M-750.77M-573.87M-642.19M-824.43M-1.11B-1.10B-

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.63M14.54M19.15M41.17M58.30M83.70M114.82M122.77M159.13M206.45M232.93M256.22M360.58M360.28M388.32M262.44M423.20M
Investing Cash Flow25.37M-737.88K-4.03M-7.25M-15.51M-78.78M-70.03M-102.57M-168.36M132.39M-606.93M-90.74M-212.31M-118.19M-112.33M-595.60M-
Financing Cash Flow-27.40M-29.87M-540.56K-11.87M-3.50M167.21M-48.48M-56.56M-40.40M-64.64M63.78M-94.25M-89.58M-111.03M-109.19M-146.58M-
Capital Expenditure21.48M10.56M3.99M7.25M17.53M22.67M31.51M35.93M34.73M57.75M99.83M70.16M122.16M188.74M209.16M117.97M119.35M
Free Cash Flow-8.85M3.98M15.16M33.92M40.77M61.04M83.31M86.84M124.41M148.70M133.10M186.06M238.42M171.54M172.92M144.47M303.85M
Dividends Paid-16.98K540.56K320.25K-30.30M48.48M56.56M40.40M64.64M72.72M94.25M83.77M105.24M104.72M97.45M115.30M
FCF to OCF-70.09%27.35%79.15%82.40%69.94%72.92%72.56%70.74%78.18%72.03%57.14%72.62%66.12%47.61%44.53%55.05%71.80%
Dividend Paid to FCF-0.43%3.57%0.94%-49.64%58.19%65.13%32.47%43.47%54.64%50.65%35.14%61.35%60.56%67.45%37.95%

Earnings

Report DateMar 31, 2014Jul 31, 2014Oct 26, 2014Feb 11, 2015Apr 22, 2015Aug 11, 2015Oct 29, 2015Feb 26, 2016Apr 21, 2016Aug 25, 2016Oct 27, 2016Apr 26, 2017Aug 7, 2017Oct 25, 2017Feb 27, 2018Apr 24, 2018Aug 15, 2018Oct 24, 2018Feb 25, 2019Apr 25, 2019Aug 14, 2019Oct 21, 2019Feb 28, 2020Apr 28, 2020Aug 19, 2020Oct 22, 2020Mar 5, 2021Apr 27, 2021Jul 15, 2021Oct 26, 2021Feb 11, 2022Apr 26, 2022Jul 20, 2022Oct 25, 2022Apr 20, 2023Aug 24, 2023Oct 25, 2023Apr 18, 2024Aug 22, 2024Oct 24, 2024Apr 18, 2025Aug 22, 2025Oct 24, 2025Apr 27, 2026Aug 28, 2026
EPS Estimate--------------------------0.18------------------
EPS Actual0.030.050.070.050.050.050.080.050.050.050.090.050.080.130.070.100.100.160.080.130.120.220.100.080.130.230.090.130.150.240.120.120.170.280.040.150.230.150.140.230.090.200.320.230.18
Surprise---------------------------50.00%------------------
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-market----

Key Statistics & Ratios

Market Cap10.64B
Enterprise Value9.35B
Trailing P/E25.41
Forward P/E0.00
Price / Sales9.74
Price / Book3.88
EPS0.80
Book Value5.26
Revenue (TTM)1.09B
Gross Profit (TTM)1.04B
EBITDA476.58M
Profit Margin38.21%
Operating Margin40.39%
Return on Equity15.03%
Return on Assets8.99%
Shares Outstanding523.58M
Shares Float263.14M
Beta0.37
Dividend Yield1.23%
Dividend Rate0.25
Payout Ratio34.33%

Dividends

20262×
0.15Jul 9, 20260.10Jan 20, 2026
20252×
0.12Jul 8, 20250.10Jan 10, 2025
20241×
0.18Jul 4, 2024
20231×
0.20Jul 6, 2023
20221×
0.20Jun 16, 2022
20211×
0.16Jun 1, 2021
20201×
0.18May 21, 2020
20191×
0.25May 8, 2019
20181×
0.12Apr 19, 2018
20171×
0.08Jun 6, 2017
20161×
0.11May 16, 2016
20141×
0.06May 23, 2014

Stock Splits

  • May 8, 20191.8:1
  • Apr 19, 20181.8:1
  • May 23, 201416:10